Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

High-grade gliomas with chromosome 1p loss.

Cavenee WK.

J Neurosurg. 2000 Jun;92(6):1080-1. No abstract available.

PMID:
10839286
3.

Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.

Kujas M, Lejeune J, Benouaich-Amiel A, Crinière E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka M, Bernier M, Chretien F, Couvelard A, Capelle L, Duffau H, Cornu P, Broët P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K, Delattre JY.

Ann Neurol. 2005 Aug;58(2):322-6.

PMID:
16049942
4.

[Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].

Fontaine D, Vandenbos F, Lebrun C, Paquis V, Frenay M.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):595-604. doi: 10.1016/j.neurol.2008.04.002. Epub 2008 May 21. Review. French.

PMID:
18565359
5.

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW.

Front Biosci. 2003 Jan 1;8:a1-9.

PMID:
12456321
6.

[Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].

Born PW, Broholm H, Laursen H.

Ugeskr Laeger. 2006 Oct 30;168(44):3813-6. Danish.

PMID:
17118240
7.

High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.

Law M, Brodsky JE, Babb J, Rosenblum M, Miller DC, Zagzag D, Gruber ML, Johnson G.

J Magn Reson Imaging. 2007 Jun;25(6):1113-9.

PMID:
17520715
8.

Two types of chromosome 1p losses with opposite significance in gliomas.

Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, Delattre O, Delattre JY.

Ann Neurol. 2005 Sep;58(3):483-7.

PMID:
16130103
9.

Gliomas: association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q.

Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Sikorska B, Papierz W, Liberski PP.

Acta Neurobiol Exp (Wars). 2007;67(2):103-12.

10.

Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.

Reddy KS.

Cancer Genet Cytogenet. 2008 Jul 15;184(2):77-86. doi: 10.1016/j.cancergencyto.2008.03.009.

PMID:
18617055
11.

Molecular genetic markers as predictors of response to chemotherapy in gliomas.

Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.

Curr Opin Oncol. 2007 Nov;19(6):606-11. Review.

PMID:
17906460
12.

[Towards a molecular classification of gliomas].

Hoang-Xuan K, Idbaih A, Mokhtari K, Sanson M.

Bull Cancer. 2005 Apr;92(4):310-6. Review. French.

13.

Correlation of 1p-19q-defects in human gliomas with the light microscopic appearance of oligodendroglioma.

McLendon RE, Rasheed A, Wiltshire R, Herndon J.

Mod Pathol. 2004 May;17(5):604-5. No abstract available.

14.

Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.

Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC.

Neuropathol Appl Neurobiol. 2009 Aug;35(4):367-79. doi: 10.1111/j.1365-2990.2008.01002.x. Epub 2008 Nov 18.

PMID:
19019173
15.

Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy.

Mariani L, Deiana G, Vassella E, Fathi AR, Murtin C, Arnold M, Vajtai I, Weis J, Siegenthaler P, Schobesberger M, Reinert MM.

J Clin Oncol. 2006 Oct 10;24(29):4758-63. Epub 2006 Sep 11.

PMID:
16966689
16.

Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.

Godfraind C, Rousseau E, Ruchoux MM, Scaravilli F, Vikkula M.

Neuropathol Appl Neurobiol. 2003 Oct;29(5):462-71.

PMID:
14507338
17.

Prognostic stratification of patients with anaplastic gliomas according to genetic profile.

Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.

Cancer. 2006 Oct 15;107(8):1891-7.

18.

[Histological and molecular classification of gliomas].

Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10. Review. French.

PMID:
18565348
19.

p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.

Jin W, Xu X, Yang T, Hua Z.

Chin Med J (Engl). 2000 Jul;113(7):662-6.

PMID:
11776043
20.

Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.

Walker C, du Plessis DG, Joyce KA, Machell Y, Thomson-Hehir J, Al Haddad SA, Broome JC, Warnke PC.

Clin Cancer Res. 2003 Oct 15;9(13):4841-51.

Supplemental Content

Support Center